Caprazamycin A has significant antibacterial activity against Mycobacterium tuberculosis (TB). The first total synthesis is herein reported and features a) the scalable preparation of the syn‐β‐hydroxy amino acid with a thiourea‐catalyzed diastereoselective aldol reaction, b) construction of a diazepanone with an unstable fatty‐acid side chain, and c) global deprotection with hydrogenation. This report provides a route for the synthesis of related liponucleoside antibiotics with fatty‐acid side chains
Mycobacterium tuberculosis kills approximately two million people each year and is second only to HI...
TB is the second leading cause of morbidity world wide caused by a single infectious organism. One t...
The oligopeptides cystobactamid and Myxovalargin A are natural products produced by myxobacteria. Bo...
The first total synthesis of caprazamycin A (1), a representative liponucleoside antibiotic, is desc...
The first total synthesis of caprazamycin A (1), a representative liponucleoside antibiotic, is desc...
Mycobacterium tuberculosis (Mtb) has recently surpassed HIV/AIDS as the leading cause of death by a ...
Despite over a century of advancement, tuberculosis remains a grave threat to world health. In parti...
The first total synthesis of the potent anti-tuberculosis cyclopeptide natural products ilamycins E1...
New antibiotic scaffolds with novel drug targets are needed to combat the rise of drug-resistant, in...
Tuberculosis (TB) is still a global disease threatening people’s lives. With the emergence of multi-...
It is estimated that roughly a quarter of the world population is infected by Tuberculosis (TB), eit...
Carbacaprazamycins, which are chemically stable analogues of caprazamycins, were designed and synthe...
Research toward the total synthesis of the promising antibiotic lactonamycin is reported. Lactonamyc...
Fidaxomicin, also known as tiacumicin B or lipiarmycin A3, is a novel macrocyclic antibiotic that is...
SummaryHuman tuberculosis is a contagious infectious disease and is regarded as a major threat to gl...
Mycobacterium tuberculosis kills approximately two million people each year and is second only to HI...
TB is the second leading cause of morbidity world wide caused by a single infectious organism. One t...
The oligopeptides cystobactamid and Myxovalargin A are natural products produced by myxobacteria. Bo...
The first total synthesis of caprazamycin A (1), a representative liponucleoside antibiotic, is desc...
The first total synthesis of caprazamycin A (1), a representative liponucleoside antibiotic, is desc...
Mycobacterium tuberculosis (Mtb) has recently surpassed HIV/AIDS as the leading cause of death by a ...
Despite over a century of advancement, tuberculosis remains a grave threat to world health. In parti...
The first total synthesis of the potent anti-tuberculosis cyclopeptide natural products ilamycins E1...
New antibiotic scaffolds with novel drug targets are needed to combat the rise of drug-resistant, in...
Tuberculosis (TB) is still a global disease threatening people’s lives. With the emergence of multi-...
It is estimated that roughly a quarter of the world population is infected by Tuberculosis (TB), eit...
Carbacaprazamycins, which are chemically stable analogues of caprazamycins, were designed and synthe...
Research toward the total synthesis of the promising antibiotic lactonamycin is reported. Lactonamyc...
Fidaxomicin, also known as tiacumicin B or lipiarmycin A3, is a novel macrocyclic antibiotic that is...
SummaryHuman tuberculosis is a contagious infectious disease and is regarded as a major threat to gl...
Mycobacterium tuberculosis kills approximately two million people each year and is second only to HI...
TB is the second leading cause of morbidity world wide caused by a single infectious organism. One t...
The oligopeptides cystobactamid and Myxovalargin A are natural products produced by myxobacteria. Bo...